| 000 | 01575 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517020636.0 | ||
| 264 | 0 | _c20151120 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2015.54 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShah, N | |
| 245 | 0 | 0 |
_aPhase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma. _h[electronic resource] |
| 260 |
_bLeukemia _cSep 2015 |
||
| 300 |
_a1945-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 |
_aMultiple Myeloma _xmortality |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThall, P F | |
| 700 | 1 | _aFox, P S | |
| 700 | 1 | _aBashir, Q | |
| 700 | 1 | _aShah, J J | |
| 700 | 1 | _aParmar, S | |
| 700 | 1 | _aLin, P | |
| 700 | 1 | _aKebriaei, P | |
| 700 | 1 | _aNieto, Y | |
| 700 | 1 | _aPopat, U R | |
| 700 | 1 | _aHosing, C M | |
| 700 | 1 | _aCornelison, A | |
| 700 | 1 | _aShpall, E J | |
| 700 | 1 | _aOrlowski, R Z | |
| 700 | 1 | _aChamplin, R E | |
| 700 | 1 | _aQazilbash, M H | |
| 773 | 0 |
_tLeukemia _gvol. 29 _gno. 9 _gp. 1945-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2015.54 _zAvailable from publisher's website |
| 999 |
_c24660281 _d24660281 |
||